Announcement of execution of concession agreement for development of High Tech Pharmaceutical Park at Dighi Port Industrial Area, Maharashtra
ORDERS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 13 Mar 2026, 06:41 PM IST · BSE ID: 2c712fee-87f8-4a08-8cc7-bb5a714e0709
View Original BSE Filing (PDF)
🤖 AI Summary
- Ramky Infrastructure's wholly owned subsidiary Maha Integrated Life Sciences City Limited signed a 95-year concession agreement with Maharashtra Industrial Development Corporation (MIDC) to develop a High-Tech Pharmaceutical Park across approximately 1,000 hectares at Dighi Port Industrial Area, Raigad district. The project estimated at INR 3,000 Crore will be executed on a Design, Build, Finance, Operate and Transfer (DBFOT) basis with a five-year construction period. The construction component is expected to add INR 3,000 Crore to Ramky's order book, bringing total order book to approximately INR 13,500 Crore. Revenue will come from land lease premiums, development charges, maintenance and operational charges for shared facilities over 90 years of operation.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Project estimated cost
INR 3,000 Crore
Construction period
5 years
Concession period
95 years
Operating period
90 years
Park area
Approximately 1,000 hectares
Updated order book
INR 13,500 Crore
👥 What This Means For Shareholders
✅
Action Required
No action required — informational filing on order execution.
👤
Who Is Affected
All shareholders benefit from order book expansion and forward revenue visibility. Subsidiary structure isolates parent company from project-specific operational risk while ensuring consolidated financial benefit.
🔍
Management Signal
Board approved large-scale PPP infrastructure project signaling confidence in execution capability and long-term concession revenue model as core growth driver alongside traditional EPC business.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Construction commencement notice and site mobilization timeline
Environmental clearance and regulatory approvals status updates
Quarterly order book updates and revenue recognition from construction phase
Operating phase revenue ramp-up tracking post-completion
MEDIUM RISK
Greenfield development execution risk, regulatory approval timelines uncertain, pharmaceutical sector tenant acquisition dependent, 95-year concession subject to policy changes.
💡 Investor Takeaway
Ramky secured INR 3,000 Crore order for a 95-year pharmaceutical park concession, raising order book to INR 13,500 Crore. Five-year construction feeds near-term revenue; 90-year operating period creates long-term cash visibility through lease and utility charges.
⚖️ Strengths & Concerns
✅ Positives
- Major order win adds INR 3,000 Crore construction value to order book, raising total to INR 13,500 Crore
- 95-year concession with long-term recurring revenue from lease premiums, development and maintenance charges provides visibility
⚠️ Concerns
- Five-year construction period represents extended project timeline before substantial revenue recognition begins
- Large-scale greenfield development across 1,000 hectares carries execution, regulatory approval, and demand realization risks
📅 Company Track Record
Ramky Infrastructure established 1994, BSE listed company. Operates across industrial infrastructure, water treatment, roads and urban development. ISO certified (9001:2015, 14001:2015, 45001:2018). Team of 2,000+ professionals. Limited specific historical financial data in current filing.
Based on publicly available historical data. For context only.